Abazistobart - HY-P991113
Catalog #
HY-P991113
Abazistobart is an immunostimulant and antineoplastic agent targeting the programmed cell death protein 1 (PDCD1). Abazistobart is a chimeric and humanized monoclonal antibody that specifically binds to PDCD1 to block the relevant signaling pathway, thereby activating the immune system and exerting antineoplastic activity. Abazistobart is promising for research of cancers[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P991113/Abazistobart-DataSheet-MedChemExpress.pdf |
|---|---|
| Quantity | Get quote |
| Shipping | Room temperature |
| Application | COVID-19-immunoregulation |
| CAS | 3002062-67-8 |
| MWT | N/A |
| Clinical Information | No Development Reported |
| Target | PD-1/PD-L1 |
| Application: | COVID-19-immunoregulation |
|---|